Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
David R Staskin & Dudley Robinson. (2009) Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder. Expert Opinion on Pharmacotherapy 10:18, pages 3103-3111.
Read now
Read now
Roger R. Dmochowski & Diane K. Newman. (2007) Impact of overactive bladder on women in the United States:results of a national survey. Current Medical Research and Opinion 23:1, pages 65-76.
Read now
Read now
M. D. Lee, E. Ayanoglu & L. Gong. (2006) Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions. Xenobiotica 36:10-11, pages 1013-1080.
Read now
Read now
Articles from other publishers (5)
Y. Qiu & P.I. Lee. 2017. Developing Solid Oral Dosage Forms. Developing Solid Oral Dosage Forms
519
554
.
Petra Krause, Uwe Fuhr, Jörg Schnitker, Uwe Albrecht, Raimund Stein & Peter Rubenwolf. (2013) Pharmacokinetics of Intravesical Versus Oral Oxybutynin in Healthy Adults: Results of an Open Label, Randomized, Prospective Clinical Study. Journal of Urology 190:5, pages 1791-1797.
Crossref
Crossref
Yihong Qiu. 2009. Developing Solid Oral Dosage Forms. Developing Solid Oral Dosage Forms
469
499
.
Stephen J. Griffin & William H. Turner. 2006. Drug Treatment in Urology. Drug Treatment in Urology
1
20
.
Michael Preik, Detlef Albrecht, Martin O'Connell, Christian Hampel & Rodney Anderson. (2004) Effect of controlled-release delivery on the pharmacokinetics of oxybutynin at different dosages: severity-dependent treatment of the overactive bladder. BJU International 94:6, pages 821-827.
Crossref
Crossref